Skip to main content
SpringerLink
Log in

Metastasiertes Nierenzellkarzinom

Ungewöhnlicher Verlauf nach Operation und autologer Tumorzellvakzinierung

  • Praxisspiegel/Kausistik
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chen L, Linsley PS, Hellström KE (1993) Co-stimulation of T cells for tumor immunity. Immunol Today 14: 483–485

    Article  CAS  PubMed  Google Scholar 

  2. De Riese W, Allhoff W, Kirchner H, Stief CG, Atzpodien J, Maschek H, Jonas U (1991) Complete spontaneous regression in metastatic renal carcinoma — an update and review. World J Urol 9: 184–191

    Google Scholar 

  3. Everson MP, McDuffie DS, Lemak DG, Koopman WJ, McGhee JR, Beagley KW (1996) Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leucocyte Biol 59: 494–498

    CAS  Google Scholar 

  4. Harris TD (1984) Semin Oncol 10: 422

    Google Scholar 

  5. Kriegmair M, Oberneder R (1995) Die Tumor-zellvakzinierung zur Behandlung des Nierenzellkarzinoms. Urologe A 34: 204–207

    CAS  PubMed  Google Scholar 

  6. Marcus PI, Svitlik C, Selellick MJ (1983) Interferon induction by viruses, X. A. model for interferon induction by Newcastle Disease Virus. J Gen Virol 64: 2419–2431

    Article  CAS  PubMed  Google Scholar 

  7. Mc Cune CS, de Kernion JB, Huben RP, Pontes JE (1984) Specific immunotherapy vs. megace for metastatic renal cell carcinoma. A prospective randomized trial. J Urol A 131: 178

    Google Scholar 

  8. Mickisch G H (1998) Nierenzellkarzinom — welcher Patient benötigt eine Immuntherapie? Urologe B [Suppl 1] 38: 27–30

    Article  Google Scholar 

  9. Raychaudhuri S, Rock KL (1998) Fully mobilizing host defense: Building better vaccines. Nat Biotechn 16: 1025–1031

    Article  CAS  Google Scholar 

  10. Schild HJ, von Hoegen P, Schirrmacher V (1989) Modification of tumor cells by a low dose of Newcastle Disease Virus: II augmentation of tumor specific T cell response as a result of CD4 + and CD8 + immune T cell cooperation. Cancer Immunol Immunother 28: 22–28

    CAS  PubMed  Google Scholar 

  11. Tallberg T, Tykkae H (1986) Specific active immunotherapy in advanced renal cell cancer; a clinical longterm follow up study. World J Urol 3: 234–244

    Article  Google Scholar 

  12. Tykkae H, Kjelt L, Oravisto KJ, Turunen M, Tallberg Th (1974) Disappearance of lung metastases during immunotherapy in five patients suffering from renal cell carcinoma. Scand J Resp Dis 89 [Suppl]: 123–128

    Google Scholar 

  13. Tykkae H, Oravisto KJ, Lethonen T, Sarna S, Tallberg T (1978) Active specific immunotherapy of advanced renal cell carcinoma. Eur Urol 4: 250–258

    Google Scholar 

  14. vonHoegen, P, Weber E, Schirrmacher V (1988) Modification of tumor cells by a low dose of Newcastle Disease Virus: I augmentation of the tumor specific T cell response in the absence of an anti-viral response. Eur J Immunol 18: 1159–1166

    Article  Google Scholar 

  15. Wagner H, Oberneder R, Busch M, Weiss M, Schmeller N, Petrides P (1997) Nierenzellkarzinom. In: Tumorzentrum München (Hrsg) Empfehlungen zur Diagnostik, Therapie und Nachsorge urogenitaler Tumoren. Schriftenreihe des Tumorzentrums München, S 74-91

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik, Klinikum St. Marien, Amberg

    W. Vogl & H. R. Osterhage

  2. Immunologisches Laboratorium Hannover, Germany

    L. Kaiser

Authors
  1. W. Vogl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. R. Osterhage
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vogl, W., Osterhage, H.R. & Kaiser, L. Metastasiertes Nierenzellkarzinom. Der Urologe B 39, 419–422 (1999). https://doi.org/10.1007/s001310050384

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050384

Search

Navigation